# A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China

> **NCT03235778** · PHASE1 · COMPLETED · sponsor: **Yiling Pharmaceutical Inc.** · enrollment: 58 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Felbinac Trometamol Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03235778
- **Lead sponsor:** Yiling Pharmaceutical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-17
- **Primary completion:** 2018-03-19
- **Final completion:** 2018-06-15
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03235778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03235778, "A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03235778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*